ClassID:

94740

C07D275/04 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems

Sub-classes:
Recent Application in this class:
#1
20250186391
2025-06-12

ORAL COMPLEMENT FACTOR D INHIBITORS

#2
20250057817
2025-02-20

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

#3
20240391886
2024-11-28

CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL DISORDERS

#4
20240174660
2024-05-30

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

#5
20240174625
2024-05-30

COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES

#6
20240076276
2024-03-07

Process for Preparing 1,2-Benzisothiazoline-3-One

#7
20220332726
2022-10-20

NITROXIDE DERIVATIVE OF ROCK KINASE INHIBITOR

#8
20220332689
2022-10-20

IDENTIFICATION OF COMPOUNDS THAT INHIBIT STRESS GRANULE FORMATION AND TAU AGGREGATION BY TARGETING TIAI

#9
20220168280
2022-06-02

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

#10
20210363098
2021-11-25

Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation

#11
20210292284
2021-09-23

Compounds useful for the treatment of infection with or

#12
20210238155
2021-08-05

Carbon monoxide prodrugs for the treatment of medical disorders

#13
20210220408
2021-07-22

ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE

#14
20210087184
2021-03-25

AMINO-BENZOISOTHIAZOLE AND AMINO-BENZOISOTHIADIAZOLE AMIDE COMPOUNDS

#15
20210060051
2021-03-04

Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents

#16
20210053044
2021-02-25

Redox dehydration coupling catalysts and methods related thereto

#17
20210009577
2021-01-14

KRAS G12C inhibitors and methods of using the same

#18
20200377457
2020-12-03

MIF MODULATORS

#19
20200069657
2020-03-05

KRAS G12C inhibitors and methods of using the same

#20
20200055845
2020-02-20

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

#21
20190271696
2019-09-05

Magnetic particle dispersion

#22
20190270706
2019-09-05

MIF modulators

#23
20190194163
2019-06-27

Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

#24
20190161878
2019-05-30

Leveling agent and electroplating composition comprising the same

#25
20190062321
2019-02-28

Histone deacetylase inhibitors and compositions and methods of use thereof

#26
20190031639
2019-01-31

Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibitors

#27
20180334454
2018-11-22

KRAS G12C inhibitors and methods of using the same

#28
20180297975
2018-10-18

Substituted ureas and methods of treating mental illness using the same

#29
20180177767
2018-06-28

KRAS G12C inhibitors and methods of using the same

#30
20180162813
2018-06-14

MIF modulators

#31
20180092908
2018-04-05

SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE

#32
20170320840
2017-11-09

Method for preparation of 2-methyl-1,2-benzisothiazolin-3-one

#33
20170305900
2017-10-26

Histone deacetylase inhibitors and compositions and methods of use thereof

#34
20170304271
2017-10-26

Isoxazole derivatives as FXR agonists and methods of use thereof

#35
20170298080
2017-10-19

Amino sulfonyl-based compounds, the preparation method therefor and use thereof

#36
20170290795
2017-10-12

URAT1 inhibitor

#37
20170036969
2017-02-09

NITRIFICATION INHIBITORS

#38
20160243534
2016-08-25

Heterocyclic coupling catalysts and methods related thereto

#39
20160157491
2016-06-09

Pesticide compounds

#40
20160151362
2016-06-02

Targeting human thymidylate kinase induces DNA repair toxicity in malignant tumor cells

#41
20160096811
2016-04-07

Benzoisothiazole compounds and methods of treating schizophrenia

#42
20160046651
2016-02-18

TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY

#43
20160031876
2016-02-04

Histone deacetylase inhibitors and compositions and methods of use thereof

#44
20150336910
2015-11-26

Synthetic method for the preparation of 1, 2-benzisothiazolin-3-one

#45
20150291541
2015-10-15

Method for preparation of 2-alkyl-1,2-benzisothiazolin-3-ones

#46
20150112080
2015-04-23

ZINC SALT OF ISOTHIAZOLONE COMPOUND, METHOD FOR REDUCING IRRITATION CAUSED BY ISOTHIAZOLONE COMPOUND, ANTIBACTERIAL AND ANTIFUNGAL METHOD USING ZINC SALT OF ISOTHIAZOLONE COMPOUND, AND ANTIBACTERIAL AND ANTIFUNGAL COMPOSITION

#47
20150037733
2015-02-05

Acrylic acid ester derivative and method for producing same, intermediate and method for producing same, high-molecular-weight compound, and photoresist composition

#48
20140336200
2014-11-13

Arylosulfonamides for the treatment of CNS diseases

#49
20140316141
2014-10-23

Process for preparing 1,2-benzoisothiazolin-3-ones

#50
20140296310
2014-10-02

Methods of treating bacterial infections with 1,2-benzisothiazolinone and isoindolinone derivatives

#51
20140284529
2014-09-25

Texturing of monocrystalline semiconductor substrates to reduce incident light reflectance

#52
20140179922
2014-06-26

Intermediate compounds and process for the preparation of lurasidone and salts thereof

#53
20140107344
2014-04-17

ZINC SALT OF ISOTHIAZOLONE COMPOUND, METHOD FOR REDUCING IRRITATION CAUSED BY ISOTHIAZOLONE COMPOUND, ANTIBACTERIAL AND ANTIFUNGAL METHOD USING ZINC SALT OF ISOTHIAZOLONE COMPOUND, AND ANTIBACTERIAL AND ANTIFUNGAL COMPOSITION

#54
20140094449
2014-04-03

Treatment of bipolar disorder

#55
20140065836
2014-03-06

Texturing of monocrystalline semiconductor substrates to reduce incident light reflectance

#56
20140018355
2014-01-16

Lisofylline analogs and methods for use

#57
20130345434
2013-12-26

METHOD FOR PRODUCING 1,2-BENZISOTHIAZOL-3-ONE COMPOUND

#58
20130345433
2013-12-26

1,2-benzisothiazol-3-one compound production method

#59
20130252953
2013-09-26

Targeting human thymidylate kinase induces DNA repair toxicity in malignant tumor cells

#60
20130245015
2013-09-19

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#61
20130150413
2013-06-13

Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators

#62
20130109864
2013-05-02

Process for preparing 1,2-benzoisothiazoline-3-one

#63
20130030189
2013-01-31

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#64
20130005983
2013-01-03

Method for producing 3-halo-1,2-benzisothiazoles

#65
20120289471
2012-11-15

NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX

#66
20120115841
2012-05-10

Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists

#67
20120094983
2012-04-19

Acyclic Iinhibitors

#68
20120071503
2012-03-22

Positive allosteric modulators of group II mGluRs

#69
20120065061
2012-03-15

Isothiazolyloxyphenylamidines and their use as fungicides

#70
20120040974
2012-02-16

MIF MODULATORS

#71
20120022253
2012-01-26

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#72
20120009519
2012-01-12

Compound, resin and photoresist composition

#73
20120004261
2012-01-05

MIF modulators

#74
20110257233
2011-10-20

BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE

#75
20110251402
2011-10-13

Zinc salt of isothiazolone compound, method for reducing irritation caused by isothiazolone compound, antibacterial and antifungal method using zinc salt of isothiazolone compound, and antibacterial and antifungal composition

#76
20110251193
2011-10-13

1,2-benzisothiazolinone and isoindolinone derivatives

#77
20110237624
2011-09-29

Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents

#78
20110190257
2011-08-04

Bicyclic heterocycles as MEK kinase inhibitors

#79
20110143270
2011-06-16

Azo compound, azo pigment, pigment dispersion, coloring composition, ink for inkjet recording, coloring composition for color filter, color filter, and process for preparing a coloring composition for color filter

#80
20110130282
2011-06-02

Isothiazolyloxyphenylamidines and their use as fungicides

#81
20110086852
2011-04-14

Pharmaceutical compounds

#82
20110082116
2011-04-07

Compounds as cannabinoid receptor ligands

#83
20110003994
2011-01-06

CYCLOALKANE DERIVATIVE

#84
20100267714
2010-10-21

MIF modulators

#85
20100234345
2010-09-16

Compounds as cannabinoid receptor ligands

#86
20100167922
2010-07-01

3-amino-1,2-benzisothiazole compounds for combating animal pest

#87
20100137272
2010-06-03

Zinc Salt Of Isothiazolone Compound, Method For Reducing Irritation Caused By Isothiazolone Compound, Antibacterial and Antifungal Method Using Zinc Salt of Isothiazolone Compound, and Antibacterial and Antifungal Composition

#88
20100130538
2010-05-27

Bicyclic compound and pharmaceutical use thereof

#89
20100069489
2010-03-18

L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX

#90
20100069446
2010-03-18

L-threonine derivatives of high therapeutic index

#91
20100048893
2010-02-25

Substituted arylalkanoic acid derivatives and use thereof

#92
20100048590
2010-02-25

N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS

#93
20100009848
2010-01-14

3-amino-1,2-benzisothiazole compounds for combating animal pest II

#94
20100004481
2010-01-07

L-Threonine derivatives of high therapeutic index

#95
20090318454
2009-12-24

NOVEL ANTIOXIDANTS AND METHODS OF TREATMENT

#96
20090312377
2009-12-17

DERIVATIVES OF BENZO[D]ISOTHIAZOLES AS HISTONES DEACETYLASE INHIBITORS

#97
20090286793
2009-11-19

PDE4B inhibitors and uses therefor

#98
20090286784
2009-11-19

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#99
20090275588
2009-11-05

N-glycinsulfonamide derivatives and uses as orexin receptor antagonists

#100
20090209532
2009-08-20

PHARMACEUTICAL COMPOUNDS

#101
20090069317
2009-03-12

Insecticidal Methods Using 3-Amino-1,2-Benzisothiazole Derivatives

#102
20090062530
2009-03-05

Substituted arylalkanoic acid derivatives and use thereof

#103
20090054430
2009-02-26

Inhibitors of protein kinases

#104
20090023789
2009-01-22

Compounds as cannabinoid receptor ligands

#105
20090023779
2009-01-22

Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents

#106
20080194557
2008-08-14

Methods and compositions for the treatment of pain, inflammation and cancer

#107
20080146544
2008-06-19

Lisofylline analogs and methods for use

#108
20080090867
2008-04-17

Azole derivatives in the form of lipase and phospholipase inhibitors

#109
20080076767
2008-03-27

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#110
20070219207
2007-09-20

Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups

#111
20070213333
2007-09-13

Substituted arylalkanoic acid derivatives and use thereof

#112
20070099985
2007-05-03

Heteroaromate OSC inhibitors

#113
20070082909
2007-04-12

Acyclic Iinhibitors

#114
20070078156
2007-04-05

Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain

#115
20060287244
2006-12-21

L-Threonine derivatives of high therapeutic index

#116
20060276522
2006-12-07

Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors

#117
20060241017
2006-10-26

Compounds with high therapeutic index

#118
20060229294
2006-10-12

Benzisothiazoles useful for treating or preventing HCV infection

#119
20060194817
2006-08-31

N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds

#120
20060173035
2006-08-03

3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake

#121
20060142587
2006-06-29

Benzoisothiazolone compositions

#122
20060128712
2006-06-15

Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups

#123
20060074115
2006-04-06

Hexafluoroisopropanol substituted ether derivatives

#124
20060058360
2006-03-16

Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors

#125
20060041006
2006-02-23

PDE4B inhibitors and uses therefor

#126
20060004080
2006-01-05

Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto

#127
20050282819
2005-12-22

Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia

#128
20050267200
2005-12-01

Heteroaromate OSC inhibitors

#129
20050227987
2005-10-13

11β-hydroxysteroid dehydrogenase inhibitors

#130
20050020603
2005-01-27

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#131
14036260
2014-11-11

Process for preparing benzisothiazolinones